
Quipt Home Medical Corp. (NASDAQ:QIPT - Free Report) - Research analysts at Leede Financial upped their FY2025 EPS estimates for shares of Quipt Home Medical in a report issued on Monday, July 7th. Leede Financial analyst D. Loe now forecasts that the company will post earnings of ($0.33) per share for the year, up from their previous estimate of ($0.35). The consensus estimate for Quipt Home Medical's current full-year earnings is ($0.05) per share. Leede Financial also issued estimates for Quipt Home Medical's FY2026 earnings at ($0.37) EPS and FY2027 earnings at ($0.33) EPS.
Other equities research analysts have also issued research reports about the stock. Canaccord Genuity Group reissued a "hold" rating and issued a $1.70 price target (down previously from $4.00) on shares of Quipt Home Medical in a report on Tuesday, May 13th. Wall Street Zen cut shares of Quipt Home Medical from a "hold" rating to a "sell" rating in a research note on Thursday, May 22nd. Finally, Benchmark reaffirmed a "buy" rating and set a $4.00 target price (down previously from $6.00) on shares of Quipt Home Medical in a research note on Wednesday, May 14th.
View Our Latest Report on Quipt Home Medical
Quipt Home Medical Price Performance
NASDAQ QIPT traded down $0.03 on Wednesday, hitting $1.87. The company had a trading volume of 135,942 shares, compared to its average volume of 402,760. The company has a market capitalization of $81.23 million, a PE ratio of -8.90 and a beta of 0.56. The company's fifty day moving average price is $1.88 and its 200-day moving average price is $2.33. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.22 and a quick ratio of 0.85. Quipt Home Medical has a 12-month low of $1.35 and a 12-month high of $4.07.
Quipt Home Medical (NASDAQ:QIPT - Get Free Report) last issued its quarterly earnings results on Monday, May 12th. The company reported ($0.07) EPS for the quarter, missing the consensus estimate of $0.02 by ($0.09). The company had revenue of $57.40 million during the quarter, compared to analysts' expectations of $88.29 million. Quipt Home Medical had a negative return on equity of 8.38% and a negative net margin of 3.66%.
Institutional Investors Weigh In On Quipt Home Medical
Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Kanen Wealth Management LLC boosted its position in shares of Quipt Home Medical by 108.4% during the 1st quarter. Kanen Wealth Management LLC now owns 2,969,541 shares of the company's stock valued at $6,919,000 after acquiring an additional 1,544,529 shares during the last quarter. Wells Fargo & Company MN boosted its position in shares of Quipt Home Medical by 30.9% during the 4th quarter. Wells Fargo & Company MN now owns 23,851 shares of the company's stock valued at $73,000 after acquiring an additional 5,625 shares during the last quarter. BNP Paribas Financial Markets acquired a new position in shares of Quipt Home Medical during the 4th quarter valued at about $137,000. Bank of America Corp DE boosted its position in shares of Quipt Home Medical by 13.5% during the 4th quarter. Bank of America Corp DE now owns 81,770 shares of the company's stock valued at $249,000 after acquiring an additional 9,757 shares during the last quarter. Finally, Arrowstreet Capital Limited Partnership boosted its position in shares of Quipt Home Medical by 74.1% during the 4th quarter. Arrowstreet Capital Limited Partnership now owns 493,858 shares of the company's stock valued at $1,506,000 after acquiring an additional 210,153 shares during the last quarter. Institutional investors and hedge funds own 42.85% of the company's stock.
Quipt Home Medical Company Profile
(
Get Free Report)
Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment.
See Also

Before you consider Quipt Home Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Quipt Home Medical wasn't on the list.
While Quipt Home Medical currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.